A Study of PLB-002 in Advanced Solid Tumors

Clinical trial NCT07304128 · RECRUITING

Trial details

NCT number: NCT07304128
Sponsor: Primelink BioTherapeitics(ShenZhen) Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2026-02-06
Primary completion: 2027-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.